MetLife Investment Management LLC Has $24.83 Million Stock Position in CME Group Inc. $CME

Key Points

• MetLife Investment Management LLC has reduced its stake in CME Group Inc. by 1.9%, now holding 93,584 shares valued at approximately $24.83 million.
• CME Group reported earnings of $2.96 EPS for the most recent quarter, surpassing analysts' expectations, with a year-over-year revenue increase of 10.4%.
• The company has declared a quarterly dividend of $1.25 per share, translating to an annualized yield of 1.9%, with a payout ratio of 48.40%.

MetLife Investment Management LLC lessened its stake in CME Group Inc. (NASDAQ:CME - Free Report) by 1.9% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 93,584 shares of the financial services provider's stock after selling 1,782 shares during the quarter. MetLife Investment Management LLC's holdings in CME Group were worth $24,827,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors also recently modified their holdings of CME. Wayfinding Financial LLC bought a new position in CME Group in the 1st quarter worth approximately $25,000. Cornerstone Planning Group LLC increased its stake in shares of CME Group by 122.2% in the 1st quarter. Cornerstone Planning Group LLC now owns 100 shares of the financial services provider's stock valued at $26,000 after buying an additional 55 shares during the period. Golden State Wealth Management LLC lifted its stake in shares of CME Group by 612.5% during the first quarter. Golden State Wealth Management LLC now owns 114 shares of the financial services provider's stock valued at $30,000 after acquiring an additional 98 shares during the period. Alpine Bank Wealth Management bought a new position in CME Group in the first quarter valued at about $32,000. Finally, Financial Gravity Asset Management Inc. bought a new position in CME Group in the first quarter valued at about $32,000. 87.75% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at CME Group

In related news, insider Sunil Cutinho sold 11,896 shares of the company's stock in a transaction on Tuesday, August 26th. The shares were sold at an average price of $271.47, for a total value of $3,229,407.12. Following the completion of the transaction, the insider directly owned 17,440 shares of the company's stock, valued at approximately $4,734,436.80. This represents a 40.55% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Charles P. Carey sold 500 shares of the stock in a transaction dated Tuesday, June 10th. The stock was sold at an average price of $265.35, for a total value of $132,675.00. Following the transaction, the director owned 4,900 shares of the company's stock, valued at approximately $1,300,215. This trade represents a 9.26% decrease in their position. The disclosure for this sale can be found here. 0.30% of the stock is currently owned by insiders.

CME Group Trading Down 1.2%

CME Group stock traded down $3.35 during mid-day trading on Thursday, hitting $266.77. 1,753,248 shares of the company's stock were exchanged, compared to its average volume of 2,319,219. The firm has a market capitalization of $96.14 billion, a P/E ratio of 25.82, a PEG ratio of 4.92 and a beta of 0.44. CME Group Inc. has a fifty-two week low of $207.75 and a fifty-two week high of $290.79. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.12. The company's 50 day simple moving average is $275.89 and its 200-day simple moving average is $268.88.

CME Group (NASDAQ:CME - Get Free Report) last posted its earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.91 by $0.05. CME Group had a return on equity of 14.60% and a net margin of 58.48%.The firm had revenue of $1.69 billion during the quarter, compared to analysts' expectations of $1.68 billion. During the same period in the previous year, the firm earned $2.56 earnings per share. The company's revenue was up 10.4% on a year-over-year basis. On average, equities analysts anticipate that CME Group Inc. will post 10.49 earnings per share for the current year.

CME Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, September 25th. Investors of record on Tuesday, September 9th will be issued a dividend of $1.25 per share. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.9%. The ex-dividend date is Tuesday, September 9th. CME Group's dividend payout ratio (DPR) is presently 48.40%.

Analyst Ratings Changes

CME has been the topic of a number of research reports. Citigroup upped their target price on shares of CME Group from $265.00 to $275.00 and gave the company a "neutral" rating in a research report on Thursday, July 3rd. Wall Street Zen lowered shares of CME Group from a "hold" rating to a "sell" rating in a report on Sunday, July 13th. UBS Group reaffirmed a "neutral" rating and set a $305.00 target price on shares of CME Group in a report on Thursday, July 24th. Piper Sandler increased their price target on CME Group from $283.00 to $296.00 and gave the company an "overweight" rating in a research note on Tuesday, July 15th. Finally, Oppenheimer raised their price target on CME Group from $300.00 to $303.00 and gave the stock an "outperform" rating in a research report on Thursday, July 24th. Four analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have given a Sell rating to the company's stock. According to data from MarketBeat, CME Group currently has a consensus rating of "Hold" and an average target price of $261.93.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.